Western Financial Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,184
Closed -$618K 120
2023
Q2
$618K Buy
1,184
+4
+0.3% +$2.16K 0.42% 73
2023
Q1
$680K Buy
1,180
+42
+4% +$23.7K 0.48% 58
2022
Q4
$627K Sell
1,138
-8
-0.7% -$4.24K 0.41% 63
2022
Q3
$581K Buy
1,146
+170
+17% +$95.1K 0.41% 64
2022
Q2
$530K Sell
976
-57
-6% -$31.4K 0.38% 57
2022
Q1
$610K Sell
1,033
-63
-6% -$36.2K 0.35% 59
2021
Q4
$731K Buy
1,096
+78
+8% +$48.7K 0.38% 57
2021
Q3
$581K Buy
1,018
+73
+8% +$40.1K 0.34% 56
2021
Q2
$477K Buy
945
+107
+13% +$50.5K 0.26% 64
2021
Q1
$383K Buy
838
+60
+8% +$28.6K 0.23% 64
2020
Q4
$362K Buy
+778
New +$365K 0.24% 64

Other funds holding TMO

Western Financial Corp's TMO Position: Q3 2023 in Review

Western Financial Corp sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 1,184 shares — an estimated $618K sold.

Western Financial Corp first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $731K in Q4 2021. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Western Financial Corp reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Western Financial Corp sold 1,184 Thermo Fisher Scientific shares in Q3 2023, an estimated $618K.
  • Western Financial Corp first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
  • Western Financial Corp's Thermo Fisher Scientific position peaked at $731K in Q4 2021.
  • 2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Western Financial Corp's 13F filing for Q3 2023, filed 19 Oct 2023.